LOS ANGELES, CA–(Marketwired – Jan 29, 2014) – Fresh Start Private Management Inc. (OTCQB: CEYY), a leader in alcohol treatment and rehabilitation programs, announced it has entered into a letter of intent to sell the exclusive license and distribution rights of its Start Fresh Program to Fresh Start NoCal, LLC. Under the terms of the pending agreement, Fresh Start NoCal, LLC will agree to pay Fresh Start Private an upfront licensing fee plus an upfront fee per program order in the states of Maryland, Virginia, West Virginia and the District of Columbia. Fresh Start NoCal currently has the rights to Northern California in a transaction that was completed in 2013.
The population of this territory is over 16.5 million people and many there can benefit from the Start Fresh Program. Within this territory, the Washington DC-Baltimore Combined Statistical Area contains nearly 10 million people and is considered the 4th largest area in the US. It also ranks first in income and education.
“We’re very happy to possibly partner with Fresh Start NoCal again for several reasons. They are already operating, so they understand and believe in our program and mission. Also, their group is made up of several experienced professionals including physicians with extensive experience in the FDA approval process,” said Kent Emry, CEO of Fresh Start Private Management, Inc. “They can be instrumental in many ways. We expect to get this agreement finalized quickly.”
About Fresh Start Private (Soon to be BioCorRx. Inc.)
Fresh Start Private Management, Inc. (OTCQB: CEYY) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a highly effective program consisting of two main components used by various alcohol addiction clinics in the US. Clinic reports show that the treatment program has an 85% success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers targeted, therapeutic levels of the drug Naltrexone, an opiate antagonist that significantly reduces physical cravings for alcohol, into the body. The second component of the program developed by Fresh Start Private is a one on one coaching program specifically tailored for the treatment of alcoholism. For more information on CEYY, visit www.freshstartprivate.com
Safe Harbor Statement
The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.
Investor Relations Contact:
Maximum Performance Advisors, Inc.